Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 147

1.

Bias and precision analysis of diffusional kurtosis imaging for different acquisition schemes.

Sprenger T, Sperl JI, Fernandez B, Golkov V, Eidner I, Sämann PG, Czisch M, Tan ET, Hardy CJ, Marinelli L, Haase A, Menzel MI.

Magn Reson Med. 2016 Jan 29. doi: 10.1002/mrm.26008. [Epub ahead of print]

PMID:
26822349
2.

Daclizumab high-yield process reduced the evolution of new gadolinium-enhancing lesions to T1 black holes in patients with relapsing-remitting multiple sclerosis.

Radue EW, Sprenger T, Vollmer T, Giovannoni G, Gold R, Havrdova E, Selmaj K, Stefoski D, You X, Elkins J.

Eur J Neurol. 2016 Feb;23(2):412-5. doi: 10.1111/ene.12922.

PMID:
26806217
3.

Efficacy and Safety of Fingolimod in an Unselected Patient Population.

Rasenack M, Rychen J, Andelova M, Naegelin Y, Stippich C, Kappos L, Lindberg RL, Sprenger T, Derfuss T.

PLoS One. 2016 Jan 6;11(1):e0146190. doi: 10.1371/journal.pone.0146190. eCollection 2016.

4.

Diffusion in realistic biophysical systems can lead to aliasing effects in diffusion spectrum imaging.

Lacerda LM, Sperl JI, Menzel MI, Sprenger T, Barker GJ, Dell'Acqua F.

Magn Reson Med. 2015 Dec 30. doi: 10.1002/mrm.26080. [Epub ahead of print]

PMID:
26714794
5.

The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosis.

Yaldizli Ö, Penner IK, Yonekawa T, Naegelin Y, Kuhle J, Pardini M, Chard DT, Stippich C, Kira JI, Bendfeldt K, Amann M, Radue EW, Kappos L, Sprenger T.

Eur J Neurol. 2015 Nov 19. doi: 10.1111/ene.12891. [Epub ahead of print]

PMID:
26699999
6.

Change in brain network connectivity during PACAP38-induced migraine attacks: A resting-state functional MRI study.

Amin FM, Hougaard A, Magon S, Asghar MS, Ahmad NN, Rostrup E, Sprenger T, Ashina M.

Neurology. 2016 Jan 12;86(2):180-7. doi: 10.1212/WNL.0000000000002261. Epub 2015 Dec 16.

PMID:
26674334
7.

Headache in acute ischaemic stroke: a lesion mapping study.

Seifert CL, Schönbach EM, Magon S, Gross E, Zimmer C, Förschler A, Tölle TR, Mühlau M, Sprenger T, Poppert H.

Brain. 2016 Jan;139(Pt 1):217-26. doi: 10.1093/brain/awv333. Epub 2015 Nov 24.

PMID:
26603369
8.

Inclusion of brain volume loss in a revised measure of 'no evidence of disease activity' (NEDA-4) in relapsing-remitting multiple sclerosis.

Kappos L, De Stefano N, Freedman MS, Cree BA, Radue EW, Sprenger T, Sormani MP, Smith T, Häring DA, Piani Meier D, Tomic D.

Mult Scler. 2015 Nov 19. pii: 1352458515616701. [Epub ahead of print]

PMID:
26585439
9.

Morphological Abnormalities of Thalamic Subnuclei in Migraine: A Multicenter MRI Study at 3 Tesla.

Magon S, May A, Stankewitz A, Goadsby PJ, Tso AR, Ashina M, Amin FM, Seifert CL, Chakravarty MM, Müller J, Sprenger T.

J Neurosci. 2015 Oct 7;35(40):13800-6. doi: 10.1523/JNEUROSCI.2154-15.2015.

PMID:
26446230
10.

Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosis.

Constantinescu CS, Asher A, Fryze W, Kozubski W, Wagner F, Aram J, Tanasescu R, Korolkiewicz RP, Dirnberger-Hertweck M, Steidl S, Libretto SE, Sprenger T, Radue EW.

Neurol Neuroimmunol Neuroinflamm. 2015 May 21;2(4):e117. doi: 10.1212/NXI.0000000000000117. eCollection 2015 Aug.

11.

Magnetization transfer ratio in lesions rather than normal-appearing brain relates to disability in patients with multiple sclerosis.

Amann M, Papadopoulou A, Andelova M, Magon S, Mueller-Lenke N, Naegelin Y, Stippich C, Radue EW, Bieri O, Kappos L, Sprenger T.

J Neurol. 2015 Aug;262(8):1909-17. doi: 10.1007/s00415-015-7793-5. Epub 2015 Jun 5.

PMID:
26041614
12.

Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS.

Kappos L, Radue EW, Comi G, Montalban X, Butzkueven H, Wiendl H, Giovannoni G, Hartung HP, Derfuss T, Naegelin Y, Sprenger T, Mueller-Lenke N, Griffiths S, von Rosenstiel P, Gottschalk R, Zhang Y, Dahlke F, Tomic D; TOFINGO study group.

Neurology. 2015 Jul 7;85(1):29-39. doi: 10.1212/WNL.0000000000001706. Epub 2015 May 29.

13.

Long-term survival of a breast cancer patient with extensive liver metastases upon immune and virotherapy: a case report.

Schirrmacher V, Stücker W, Lulei M, Bihari AS, Sprenger T.

Immunotherapy. 2015;7(8):855-60. doi: 10.2217/imt.15.48. Epub 2015 May 28.

14.

The premonitory phase of migraine--what can we learn from it?

Maniyar FH, Sprenger T, Monteith T, Schankin CJ, Goadsby PJ.

Headache. 2015 May;55(5):609-20. doi: 10.1111/head.12572. Epub 2015 Apr 28.

PMID:
25919990
15.

HER-2 and HER-3 expression in liver metastases of patients with colorectal cancer.

Styczen H, Nagelmeier I, Beissbarth T, Nietert M, Homayounfar K, Sprenger T, Boczek U, Stanek K, Kitz J, Wolff HA, Ghadimi BM, Middel P, Liersch T, Rüschoff J, Conradi LC.

Oncotarget. 2015 Jun 20;6(17):15065-76.

16.

MRI characteristics of periaqueductal lesions in multiple sclerosis.

Papadopoulou A, Naegelin Y, Weier K, Amann M, Hirsch J, von Felten S, Yaldizli O, Sprenger T, Radue EW, Kappos L, Gass A.

Mult Scler Relat Disord. 2014 Jul;3(4):542-51. doi: 10.1016/j.msard.2014.01.001. Epub 2014 Jan 18.

PMID:
25877067
17.

Comprehensive lymph node morphometry in rectal cancer using acetone compression.

Scheel AH, Reineke RA, Sprenger T, Lokka S, Kitz J, Ghadimi BM, Rüschoff J, Liersch T, Middel P.

J Clin Pathol. 2015 Jun;68(6):458-64. doi: 10.1136/jclinpath-2014-202555. Epub 2015 Mar 16.

PMID:
25779094
18.

Safety of teriflunomide for the management of relapsing-remitting multiple sclerosis.

Papadopoulou A, Kappos L, Sprenger T.

Expert Opin Drug Saf. 2015 May;14(5):749-59. doi: 10.1517/14740338.2015.1014795. Epub 2015 Feb 17. Review.

PMID:
25687236
19.

Genetic associations with brain cortical thickness in multiple sclerosis.

Matsushita T, Madireddy L, Sprenger T, Khankhanian P, Magon S, Naegelin Y, Caverzasi E, Lindberg RL, Kappos L, Hauser SL, Oksenberg JR, Henry R, Pelletier D, Baranzini SE.

Genes Brain Behav. 2015 Feb;14(2):217-27. doi: 10.1111/gbb.12190. Epub 2015 Mar 5.

PMID:
25684059
20.

Fingolimod effect on brain volume loss independently contributes to its effect on disability.

Sormani MP, De Stefano N, Francis G, Sprenger T, Chin P, Radue EW, Kappos L.

Mult Scler. 2015 Jun;21(7):916-24. doi: 10.1177/1352458515569099. Epub 2015 Feb 6.

PMID:
25662353
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk